1 active not recruiting, 1 suspended. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Suspended 1 |
| Phase 2 | 1 | Active not recruiting 1 |
Follow Recurrent Childhood Osteosarcoma: new trials by email Literature Review of Recurrent Childhood Osteosarcoma trials Research Report on Recurrent Childhood Osteosarcoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Testing a New Immune Cell Therapy, GD2-Targeted Modified T-cells (GD2CART), in Children, Adolescents, and Young Adults With Relapsed/Refractory Osteosarcoma and Neuroblastoma, GD2-CAR PERSIST Trial Biopsy Procedure, Biospecimen Collection, Bone Marrow Aspiration - Recurrent Childhood Neuroblastoma, Recurrent Childhood Osteosarcoma | Phase 1 | Suspended | National Cancer Institute (NCI) | 73 | 2022-01-25 | 2026-08-05 |
| Erdafitinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With FGFR Mutations (A Pediatric MATCH Treatment Trial) Biospecimen Collection, Bone Marrow Aspiration and Biopsy, Bone Scan - Advanced Malignant Solid Neoplasm, Recurrent Childhood Ependymoma | Phase 2 | Active not recruiting | National Cancer Institute (NCI) | 20 | 2018-06-05 | 2026-10-16 |
Neuroblastoma (2) · Central Nervous System Neoplasms (1) · Ependymoma (1) · Familial ependymoma (1) · Glioma (1) · Hepatoblastoma (1) · Histiocytosis, Langerhans-Cell (1) · Lymphoma, Non-Hodgkin (1) · Medulloblastoma (1) · Neuroectodermal Tumors, Primitive, Peripheral (1) · Osteosarcoma (1) · Rhabdoid Tumor (1) · Wilms Tumor (1)
Neoplasms (2) · Neoplasms by Histologic Type (2) · Neoplasms, Germ Cell and Embryonal (2) · Neoplasms, Glandular and Epithelial (2) · Neoplasms, Nerve Tissue (2) · Neoplasms, Neuroepithelial (2) · Neuroectodermal Tumors (2) · Neuroectodermal Tumors, Primitive (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Genetic Diseases, Inborn (1) · Hemic and Lymphatic Diseases (1) · Histiocytosis (1) · Immune System Diseases (1)
Biopsy (2) · Specimen Handling (2) · X-Rays (2) · Cyclophosphamide (1) · Magnetic Resonance Spectroscopy (1) · Nuclear Medicine Department, Hospital (1) · Phantoms, Imaging (1) · erdafitinib (1) · fludarabine phosphate (1)
National Cancer Institute (NCI) (2)
United States (2) · Puerto Rico (1)
Alice Lee (1) · Rosandra N Kaplan (1)
U10CA180886 (1), U24CA224309 (1), UM1CA081457 (1), UM1CA154967 (1), UM1CA228823 (1)